-
1
-
-
4744366279
-
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
-
2-s2.0-4744366279 10.1056/NEJMoa040720
-
Tannock I. F., De Wit R., Berry W. R., Horti J., Pluzanska A., Chi K. N., Oudard S., Théodore C., James N. D., Turesson I., Rosenthal M. A., Eisenberger M. A., Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. New England Journal of Medicine 2004 351 15 1502 1512 2-s2.0-4744366279 10.1056/NEJMoa040720
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.15
, pp. 1502-1512
-
-
Tannock, I.F.1
De Wit, R.2
Berry, W.R.3
Horti, J.4
Pluzanska, A.5
Chi, K.N.6
Oudard, S.7
Théodore, C.8
James, N.D.9
Turesson, I.10
Rosenthal, M.A.11
Eisenberger, M.A.12
-
2
-
-
4744337716
-
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
-
2-s2.0-4744337716 10.1056/NEJMoa041318
-
Petrylak D. P., Tangen C. M., Hussain M. H. A., Lara P. N. Jr., Jones J. A., Taplin M. E., Burch P. A., Berry D., Moinpour C., Kohli M., Benson M. C., Small E. J., Raghavan D., Crawford E. D., Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. New England Journal of Medicine 2004 351 15 1513 1520 2-s2.0-4744337716 10.1056/NEJMoa041318
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.15
, pp. 1513-1520
-
-
Petrylak, D.P.1
Tangen, C.M.2
Hussain, M.H.A.3
Lara Jr., P.N.4
Jones, J.A.5
Taplin, M.E.6
Burch, P.A.7
Berry, D.8
Moinpour, C.9
Kohli, M.10
Benson, M.C.11
Small, E.J.12
Raghavan, D.13
Crawford, E.D.14
-
3
-
-
84873840112
-
Tubulin-targeted agents including docetaxel and cabazitaxel
-
Cheetham P., Petrylak D. P., Tubulin-targeted agents including docetaxel and cabazitaxel. Cancer Journal 2013 19 1 59 65
-
(2013)
Cancer Journal
, vol.19
, Issue.1
, pp. 59-65
-
-
Cheetham, P.1
Petrylak, D.P.2
-
4
-
-
84859391098
-
Abiraterone in prostate cancer: A new angle to an old problem
-
2-s2.0-84859391098 10.1158/1078-0432.CCR-11-1805
-
Stein M. N., Goodin S., DiPaola R. S., Abiraterone in prostate cancer: a new angle to an old problem. Clinical Cancer Research 2012 18 7 1848 1854 2-s2.0-84859391098 10.1158/1078-0432.CCR-11-1805
-
(2012)
Clinical Cancer Research
, vol.18
, Issue.7
, pp. 1848-1854
-
-
Stein, M.N.1
Goodin, S.2
DiPaola, R.S.3
-
5
-
-
16844381317
-
Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: Tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro
-
2-s2.0-16844381317 10.1158/0008-5472.CAN-04-3502
-
Bai J., Sui J., Demirjian A., Vollmer C. M. Jr., Marasco W., Callery M. P., Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Cancer Research 2005 65 6 2344 2352 2-s2.0-16844381317 10.1158/0008-5472.CAN-04-3502
-
(2005)
Cancer Research
, vol.65
, Issue.6
, pp. 2344-2352
-
-
Bai, J.1
Sui, J.2
Demirjian, A.3
Vollmer Jr., C.M.4
Marasco, W.5
Callery, M.P.6
-
6
-
-
0037249833
-
BCL-2 in prostate cancer: A minireview
-
2-s2.0-0037249833 10.1023/A:1021692801278
-
Catz S. D., Johnson J. L., BCL-2 in prostate cancer: a minireview. Apoptosis 2003 8 1 29 37 2-s2.0-0037249833 10.1023/A:1021692801278
-
(2003)
Apoptosis
, vol.8
, Issue.1
, pp. 29-37
-
-
Catz, S.D.1
Johnson, J.L.2
-
7
-
-
36349000335
-
Doxazosin-induced clusterin expression and apoptosis in prostate cancer cells
-
2-s2.0-36349000335 10.1016/j.urolonc.2007.02.010
-
Youm Y. H., Yang H., Yoon Y.-D., Kim D.-Y., Lee C., Yoo T. K., Doxazosin-induced clusterin expression and apoptosis in prostate cancer cells. Urologic Oncology 2007 25 6 483 488 2-s2.0-36349000335 10.1016/j.urolonc.2007. 02.010
-
(2007)
Urologic Oncology
, vol.25
, Issue.6
, pp. 483-488
-
-
Youm, Y.H.1
Yang, H.2
Yoon, Y.-D.3
Kim, D.-Y.4
Lee, C.5
Yoo, T.K.6
-
8
-
-
4644237335
-
Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer
-
2-s2.0-4644237335 10.1158/0008-5472.CAN-03-3998
-
Rocchi P., So A., Kojima S., Signaevsky M., Beraldi E., Fazli L., Hurtado-Coll A., Yamanaka K., Gleave M., Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Research 2004 64 18 6595 6602 2-s2.0-4644237335 10.1158/0008-5472.CAN-03-3998
-
(2004)
Cancer Research
, vol.64
, Issue.18
, pp. 6595-6602
-
-
Rocchi, P.1
So, A.2
Kojima, S.3
Signaevsky, M.4
Beraldi, E.5
Fazli, L.6
Hurtado-Coll, A.7
Yamanaka, K.8
Gleave, M.9
-
9
-
-
53749093700
-
Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer
-
2-s2.0-53749093700 10.1111/j.1600-0463.2008.01051.x
-
Glaessgen A., Jonmarker S., Lindberg A., Nilsson B., Lewensohn R., Ekman P., Valdman A., Egevad L., Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 2008 116 10 888 895 2-s2.0-53749093700 10.1111/j.1600-0463.2008. 01051.x
-
(2008)
Acta Pathologica, Microbiologica, et Immunologica Scandinavica
, vol.116
, Issue.10
, pp. 888-895
-
-
Glaessgen, A.1
Jonmarker, S.2
Lindberg, A.3
Nilsson, B.4
Lewensohn, R.5
Ekman, P.6
Valdman, A.7
Egevad, L.8
-
10
-
-
39049148397
-
Cellular FLICE-like inhibitory protein (C-FLIP): A novel target for cancer therapy
-
2-s2.0-39049148397 10.2174/156800908783497087
-
Safa A. R., Day T. W., Wu C.-H., Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Current Cancer Drug Targets 2008 8 1 37 46 2-s2.0-39049148397 10.2174/156800908783497087
-
(2008)
Current Cancer Drug Targets
, vol.8
, Issue.1
, pp. 37-46
-
-
Safa, A.R.1
Day, T.W.2
Wu, C.-H.3
-
11
-
-
33750706551
-
Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer
-
2-s2.0-33750706551 10.1158/1078-0432.CCR-06-0133
-
Pootrakul L., Datar R. H., Shi S.-R., Cai J., Hawes D., Groshen S. G., Lee A. S., Cote R. J., Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer. Clinical Cancer Research 2006 12 20 5987 5993 2-s2.0-33750706551 10.1158/1078-0432.CCR-06-0133
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.20
, pp. 5987-5993
-
-
Pootrakul, L.1
Datar, R.H.2
Shi, S.-R.3
Cai, J.4
Hawes, D.5
Groshen, S.G.6
Lee, A.S.7
Cote, R.J.8
-
12
-
-
76749144766
-
Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer
-
2-s2.0-76749144766 10.1158/1078-0432.CCR-09-2917
-
Zoubeidi A., Chi K., Gleave M., Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer. Clinical Cancer Research 2010 16 4 1088 1093 2-s2.0-76749144766 10.1158/1078-0432.CCR-09-2917
-
(2010)
Clinical Cancer Research
, vol.16
, Issue.4
, pp. 1088-1093
-
-
Zoubeidi, A.1
Chi, K.2
Gleave, M.3
-
13
-
-
62349088789
-
Apoptosis versus cell differentiation: Role of heat shock proteins HSP90, HSP70 and HSP27
-
2-s2.0-62349088789
-
Lanneau D., de Thonel A., Maurel S., Didelot C., Garrido C., Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27. Prion 2007 1 1 53 60 2-s2.0-62349088789
-
(2007)
Prion
, vol.1
, Issue.1
, pp. 53-60
-
-
Lanneau, D.1
De Thonel, A.2
Maurel, S.3
Didelot, C.4
Garrido, C.5
-
14
-
-
0034671358
-
Heat shock protein expression independently predicts clinical outcome in prostate cancer
-
2-s2.0-0034671358
-
Cornford P. A., Dodson A. R., Parsons K. F., Desmond A. D., Woolfenden A., Fordham M., Neoptolemos J. P., Ke Y., Foster C. S., Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Research 2000 60 24 7099 7105 2-s2.0-0034671358
-
(2000)
Cancer Research
, vol.60
, Issue.24
, pp. 7099-7105
-
-
Cornford, P.A.1
Dodson, A.R.2
Parsons, K.F.3
Desmond, A.D.4
Woolfenden, A.5
Fordham, M.6
Neoptolemos, J.P.7
Ke, Y.8
Foster, C.S.9
-
15
-
-
67650976756
-
Expression of heat shock protein 27 according to Gleason score and pathologic stage of prostate cancer
-
2-s2.0-67650976756 10.4111/kju.2009.50.6.547
-
Lee S. L., Kim E. K., Kim S. S., Uh S. H., Cha K. C., Yoo T. K., Expression of heat shock protein 27 according to Gleason score and pathologic stage of prostate cancer. Korean Journal of Urology 2009 50 6 547 552 2-s2.0-67650976756 10.4111/kju.2009.50.6.547
-
(2009)
Korean Journal of Urology
, vol.50
, Issue.6
, pp. 547-552
-
-
Lee, S.L.1
Kim, E.K.2
Kim, S.S.3
Uh, S.H.4
Cha, K.C.5
Yoo, T.K.6
-
16
-
-
56549112480
-
C-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells
-
2-s2.0-56549112480 10.1016/j.bcp.2008.09.007
-
Day T. W., Huang S., Safa A. R., c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells. Biochemical Pharmacology 2008 76 12 1694 1704 2-s2.0-56549112480 10.1016/j.bcp.2008.09.007
-
(2008)
Biochemical Pharmacology
, vol.76
, Issue.12
, pp. 1694-1704
-
-
Day, T.W.1
Huang, S.2
Safa, A.R.3
-
17
-
-
4944248109
-
Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer
-
2-s2.0-4944248109 10.1158/0008-5472.CAN-04-1498
-
Zhang X., Jin T.-G., Yang H., Dewolf W. C., Khosravi-Far R., Olumi A. F., Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer. Cancer Research 2004 64 19 7086 7091 2-s2.0-4944248109 10.1158/0008-5472.CAN-04-1498
-
(2004)
Cancer Research
, vol.64
, Issue.19
, pp. 7086-7091
-
-
Zhang, X.1
Jin, T.-G.2
Yang, H.3
Dewolf, W.C.4
Khosravi-Far, R.5
Olumi, A.F.6
-
18
-
-
34447515452
-
C-FLIP expression in colorectal carcinomas: Association with Fas/FasL expression and prognostic implications
-
2-s2.0-34447515452 10.1111/j.1365-2559.2007.02723.x
-
Korkolopoulou P., Saetta A. A., Levidou G., Gigelou F., Lazaris A., Thymara I., Scliri M., Bousboukea K., Michalopoulos N. V., Apostolikas N., Konstantinidou A., Tzivras M., Patsouris E., c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications. Histopathology 2007 51 2 150 156 2-s2.0-34447515452 10.1111/j.1365-2559.2007. 02723.x
-
(2007)
Histopathology
, vol.51
, Issue.2
, pp. 150-156
-
-
Korkolopoulou, P.1
Saetta, A.A.2
Levidou, G.3
Gigelou, F.4
Lazaris, A.5
Thymara, I.6
Scliri, M.7
Bousboukea, K.8
Michalopoulos, N.V.9
Apostolikas, N.10
Konstantinidou, A.11
Tzivras, M.12
Patsouris, E.13
-
19
-
-
2942605086
-
C-FLIP expression in bladder urothelial carcinomas: Its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations
-
2-s2.0-2942605086 10.1016/j.urology.2004.01.007
-
Korkolopoulou P., Goudopoulou A., Voutsinas G., Thomas-Tsagli E., Kapralos P., Patsouris E., Saetta A. A., c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations. Urology 2004 63 6 1198 1204 2-s2.0-2942605086 10.1016/j.urology.2004.01.007
-
(2004)
Urology
, vol.63
, Issue.6
, pp. 1198-1204
-
-
Korkolopoulou, P.1
Goudopoulou, A.2
Voutsinas, G.3
Thomas-Tsagli, E.4
Kapralos, P.5
Patsouris, E.6
Saetta, A.A.7
-
20
-
-
71949119903
-
C-FLIP gene silencing eliminates tumor cells in breast cancer xenografts without affecting stromal cells
-
2-s2.0-71949119903
-
Day T. W., Sinn A. L., Huang S., Pollok K. E., Sandusky G. E., Safa A. R., C-FLIP gene silencing eliminates tumor cells in breast cancer xenografts without affecting stromal cells. Anticancer Research 2009 29 10 3883 3886 2-s2.0-71949119903
-
(2009)
Anticancer Research
, vol.29
, Issue.10
, pp. 3883-3886
-
-
Day, T.W.1
Sinn, A.L.2
Huang, S.3
Pollok, K.E.4
Sandusky, G.E.5
Safa, A.R.6
-
21
-
-
66449091211
-
Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis
-
2-s2.0-66449091211 10.1158/1535-7163.MCT-09-0058
-
Kaulfuß S., Burfeind P., Gaedcke J., Scharf J.-G., Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis. Molecular Cancer Therapeutics 2009 8 4 821 833 2-s2.0-66449091211 10.1158/1535-7163.MCT-09-0058
-
(2009)
Molecular Cancer Therapeutics
, vol.8
, Issue.4
, pp. 821-833
-
-
Kaulfuß, S.1
Burfeind, P.2
Gaedcke, J.3
Scharf, J.-G.4
-
22
-
-
0037079614
-
Quinazoline-derived α 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an α 1-adrenoceptor-independent action
-
2-s2.0-0037079614
-
Benning C. M., Kyprianou N., Quinazoline-derived α 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an α 1-adrenoceptor-independent action. Cancer Research 2002 62 2 597 602 2-s2.0-0037079614
-
(2002)
Cancer Research
, vol.62
, Issue.2
, pp. 597-602
-
-
Benning, C.M.1
Kyprianou, N.2
-
23
-
-
31544446659
-
Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway
-
2-s2.0-31544446659 10.1158/0008-5472.CAN-05-2039
-
Garrison J. B., Kyprianou N., Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cancer Research 2006 66 1 464 472 2-s2.0-31544446659 10.1158/0008-5472.CAN-05-2039
-
(2006)
Cancer Research
, vol.66
, Issue.1
, pp. 464-472
-
-
Garrison, J.B.1
Kyprianou, N.2
-
24
-
-
71349084602
-
Apoptosis induction by doxazosin and other quinazoline α 1-adrenoceptor antagonists: A new mechanism for cancer treatment?
-
2-s2.0-71349084602 10.1007/s00210-009-0462-4
-
Kyprianou N., Vaughan T. B., Michel M. C., Apoptosis induction by doxazosin and other quinazoline α 1-adrenoceptor antagonists: a new mechanism for cancer treatment? Naunyn-Schmiedeberg's Archives of Pharmacology 2009 380 6 473 477 2-s2.0-71349084602 10.1007/s00210-009-0462-4
-
(2009)
Naunyn-Schmiedeberg's Archives of Pharmacology
, vol.380
, Issue.6
, pp. 473-477
-
-
Kyprianou, N.1
Vaughan, T.B.2
Michel, M.C.3
-
25
-
-
0037376011
-
Doxazosin and terazosin suppress prostate growth by inducing apoptosis: Clinical significance
-
2-s2.0-0037376011 10.1097/01.ju.0000033280.29453.72
-
Kyprianou N., Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. Journal of Urology 2003 169 4 1520 1525 2-s2.0-0037376011 10.1097/01.ju.0000033280.29453.72
-
(2003)
Journal of Urology
, vol.169
, Issue.4
, pp. 1520-1525
-
-
Kyprianou, N.1
-
26
-
-
0346433892
-
RNA interference in functional genomics and medicine
-
2-s2.0-0346433892
-
Kim V. N., RNA interference in functional genomics and medicine. Journal of Korean Medical Science 2003 18 3 309 318 2-s2.0-0346433892
-
(2003)
Journal of Korean Medical Science
, vol.18
, Issue.3
, pp. 309-318
-
-
Kim, V.N.1
-
27
-
-
28244456529
-
Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis
-
2-s2.0-28244456529 10.1158/0008-5472.CAN-05-1840
-
Rocchi P., Beraldi E., Ettinger S., Fazli L., Vessella R. L., Nelson C., Gleave M., Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Cancer Research 2005 65 23 11083 11093 2-s2.0-28244456529 10.1158/0008-5472.CAN-05-1840
-
(2005)
Cancer Research
, vol.65
, Issue.23
, pp. 11083-11093
-
-
Rocchi, P.1
Beraldi, E.2
Ettinger, S.3
Fazli, L.4
Vessella, R.L.5
Nelson, C.6
Gleave, M.7
-
28
-
-
32544438637
-
C-FLIP inhibits chemotherapy-induced colorectal cancer cell death
-
2-s2.0-32544438637 10.1038/sj.onc.1209122
-
Longley D. B., Wilson T. R., McEwan M., Allen W. L., McDermott U., Galligan L., Johnston P. G., c-FLIP inhibits chemotherapy-induced colorectal cancer cell death. Oncogene 2006 25 6 838 848 2-s2.0-32544438637 10.1038/sj.onc.1209122
-
(2006)
Oncogene
, vol.25
, Issue.6
, pp. 838-848
-
-
Longley, D.B.1
Wilson, T.R.2
McEwan, M.3
Allen, W.L.4
McDermott, U.5
Galligan, L.6
Johnston, P.G.7
-
29
-
-
84874541618
-
Inhibition of androgen receptor expression with small interfering RNA enhances cancer cell apoptosis by suppressing survival factors in androgen insensitive, late stage LNCaP cells
-
519397 10.1155/2013/519397
-
Kim S. S., Cho H. J., Kang J. Y., Kang H. K., Yoo T. K., Inhibition of androgen receptor expression with small interfering RNA enhances cancer cell apoptosis by suppressing survival factors in androgen insensitive, late stage LNCaP cells. The Scientific World Journal 2013 2013 8 519397 10.1155/2013/519397
-
(2013)
The Scientific World Journal
, vol.2013
, pp. 8
-
-
Kim, S.S.1
Cho, H.J.2
Kang, J.Y.3
Kang, H.K.4
Yoo, T.K.5
|